TY - BOOK AU - Institute of Medicine A2 - Robert Graham A2 - Margaret A. McCoy A2 - Andrea M. Schultz TI - Strategies to Improve Cardiac Arrest Survival: A Time to Act SN - DO - 10.17226/21723 PY - 2015 UR - https://nap.nationalacademies.org/catalog/21723/strategies-to-improve-cardiac-arrest-survival-a-time-to-act PB - The National Academies Press CY - Washington, DC LA - English KW - Health and Medicine AB - Cardiac arrest can strike a seemingly healthy individual of any age, race, ethnicity, or gender at any time in any location, often without warning. Cardiac arrest is the third leading cause of death in the United States, following cancer and heart disease. Four out of five cardiac arrests occur in the home, and more than 90 percent of individuals with cardiac arrest die before reaching the hospital. First and foremost, cardiac arrest treatment is a community issue - local resources and personnel must provide appropriate, high-quality care to save the life of a community member. Time between onset of arrest and provision of care is fundamental, and shortening this time is one of the best ways to reduce the risk of death and disability from cardiac arrest. Specific actions can be implemented now to decrease this time, and recent advances in science could lead to new discoveries in the causes of, and treatments for, cardiac arrest. However, specific barriers must first be addressed. Strategies to Improve Cardiac Arrest Survival examines the complete system of response to cardiac arrest in the United States and identifies opportunities within existing and new treatments, strategies, and research that promise to improve the survival and recovery of patients. The recommendations of Strategies to Improve Cardiac Arrest Survival provide high-priority actions to advance the field as a whole. This report will help citizens, government agencies, and private industry to improve health outcomes from sudden cardiac arrest across the United States. ER - TY - BOOK AU - Institute of Medicine TI - A Nationwide Framework for Surveillance of Cardiovascular and Chronic Lung Diseases SN - DO - 10.17226/13145 PY - 2011 UR - https://nap.nationalacademies.org/catalog/13145/a-nationwide-framework-for-surveillance-of-cardiovascular-and-chronic-lung-diseases PB - The National Academies Press CY - Washington, DC LA - English KW - Health and Medicine AB - Chronic diseases are common and costly, yet they are also among the most preventable health problems. Comprehensive and accurate disease surveillance systems are needed to implement successful efforts which will reduce the burden of chronic diseases on the U.S. population. A number of sources of surveillance data—including population surveys, cohort studies, disease registries, administrative health data, and vital statistics—contribute critical information about chronic disease. But no central surveillance system provides the information needed to analyze how chronic disease impacts the U.S. population, to identify public health priorities, or to track the progress of preventive efforts. A Nationwide Framework for Surveillance of Cardiovascular and Chronic Lung Diseases outlines a conceptual framework for building a national chronic disease surveillance system focused primarily on cardiovascular and chronic lung diseases. This system should be capable of providing data on disparities in incidence and prevalence of the diseases by race, ethnicity, socioeconomic status, and geographic region, along with data on disease risk factors, clinical care delivery, and functional health outcomes. This coordinated surveillance system is needed to integrate and expand existing information across the multiple levels of decision making in order to generate actionable, timely knowledge for a range of stakeholders at the local, state or regional, and national levels. The recommendations presented in A Nationwide Framework for Surveillance of Cardiovascular and Chronic Lung Diseases focus on data collection, resource allocation, monitoring activities, and implementation. The report also recommends that systems evolve along with new knowledge about emerging risk factors, advancing technologies, and new understanding of the basis for disease. This report will inform decision-making among federal health agencies, especially the Department of Health and Human Services; public health and clinical practitioners; non-governmental organizations; and policy makers, among others. ER - TY - BOOK AU - National Academies of Sciences, Engineering, and Medicine A2 - Kathleen Stratton A2 - Leslie Y. Kwan A2 - David L. Eaton TI - Public Health Consequences of E-Cigarettes SN - DO - 10.17226/24952 PY - 2018 UR - https://nap.nationalacademies.org/catalog/24952/public-health-consequences-of-e-cigarettes PB - The National Academies Press CY - Washington, DC LA - English KW - Health and Medicine AB - Millions of Americans use e-cigarettes. Despite their popularity, little is known about their health effects. Some suggest that e-cigarettes likely confer lower risk compared to combustible tobacco cigarettes, because they do not expose users to toxicants produced through combustion. Proponents of e-cigarette use also tout the potential benefits of e-cigarettes as devices that could help combustible tobacco cigarette smokers to quit and thereby reduce tobacco-related health risks. Others are concerned about the exposure to potentially toxic substances contained in e-cigarette emissions, especially in individuals who have never used tobacco products such as youth and young adults. Given their relatively recent introduction, there has been little time for a scientific body of evidence to develop on the health effects of e-cigarettes. Public Health Consequences of E-Cigarettes reviews and critically assesses the state of the emerging evidence about e-cigarettes and health. This report makes recommendations for the improvement of this research and highlights gaps that are a priority for future research. ER -